H eart failure with preserved ejection fraction (HFpEF) is the most common form of HF, is nearly unique to the older population, particularly older women, and is increasing in prevalence (1, 2) . HFpEF has a distinct pathophysiology compared to heart failure with reduced ejection fraction and thus warrants distinct targeted treatment (3).
Exercise intolerance is the primary clinical feature in chronic HFpEF and is a major determinant of these patients' severely reduced quality of life (4) .
Endurance exercise training is currently the only therapy proven to improve aerobic capacity in older HFpEF patients (5) (6) (7) . Medications tested to date, most of which have primarily targeted cardiac mechanisms, have been unsuccessful (8) (9) (10) .
We reported that, in older HFpEF patients, noncardiac factors contribute significantly to their exercise intolerance and are the major contributors to exercise improvement following endurance exercise training (7, 11, 12) . Specifically, skeletal muscle abnormalities, by National Institutes of Health grants R01AG18915, R01AG045551, P30AG021332, and HL058091; the Kermit Glenn Phillips II Chair in Cardiovascular Medicine, Wake Forest School of Medicine; the Moritz Chair in Geriatrics, College of Nursing and Health including reduced capillary density, percentage of type I oxidative fibers, and mitochondrial mass and function coupled with impaired skeletal muscle perfusion may contribute significantly to reduced exercise tolerance in older HFpEF patients (5, (13) (14) (15) .
Moreover, it has been suggested that impaired perfusion results are due, at least partially, to low availability of the vasodilator nitric oxide (NO) (16) .
Emerging evidence suggests that dietary inorganic nitrate (NO 3 -) supplementation has beneficial effects on blood pressure control, vascular health, exercise capacity, and oxygen metabolism though targeted NO production (17) (18) (19) . It is important to discern inorganic nitrate from organic nitrates such as nitroglycerine and isosorbide mononitrate. The latter was recently shown to decrease daily activity and not affect exercise capacity in patients with HFpEF (20) .
Both of these compounds are thought to produce NO or one of its active congeners, but the pharmacokinetics differ considerably between them. Organic nitrates rapidly release relatively large amounts of NO, whereas inorganic nitrate slowly produces NO and thereby produces milder but sustained vasodilation (21, 22) . Perhaps most importantly, inorganic nitrate, through its conversion to inorganic nitrite, targets NO delivery to areas of low oxygen and low pH, such as occur in skeletal muscle during exercise (21-23).
Dietary NO 3 -is particularly abundant in beetroot juice (BRJ). Indeed, BRJ supplementation has been shown in multiple studies to improve exercise performance and oxygen metabolism in younger healthy individuals (24) (25) (26) (27) (28) (29) (30) (31) and in older patients with peripheral arterial disease (32) . Specifically, BRJ supplementation has been shown to increase time to exhaustion during high-intensity exercise and to reduce oxygen consumption (VO 2 ) during submaximal exercise (i.e. reduce oxygen cost at a given submaximal work rate) (25, 28, 29, 32) .
In healthy older adults, BRJ supplementation improved VO 2 kinetics but did not alter overall exercise performance or the oxygen cost of exercise (33) ,
and not all studies in younger adults have shown a positive effect (34) (35) (36) . In addition, some positive effects were seen after 1 week of daily doses that were not seen after a single, acute dose (29, 31) . In a recent study in patients with HFpEF, a single, acute BRJ dose (12.9 mmol) increased total work performed and cardiac output while decreasing systemic vascular resistance during a maximal exercise test but did not affect exercise efficiency (as defined by total work/ total oxygen consumed) compared to placebo (37 Figure 1) . We initially screened 252 patients from previous study participant lists, electronic medical records, and community advertisements. Importantly, participants were unaware whether they were consuming BRJ or placebo during the 1 week of daily doses. For all visits, the participant consumed the juice w45 min before arriving at the clinic.
NITRITE AND NITRATE. After 10 min of supine rest (w1 h after the participant consumed the juice), venous blood samples were drawn into 4-ml lithium heparin tubes and centrifuged at 4,000 rpm at 20 C for 3 min within 1 minute of collection. Plasma was transferred in 400-ml volumes to sterile 500-ml polypropylene microtubes (Sarstedt, Nümbrecht, Germany) containing no additives and frozen at À70 C for later analysis.
Nitrite (NO 2 -) and nitrate were measured as described previously (42), using an ENO-20 nitric oxide analyzer (EICOM, San Diego, California).
EXERCISE TESTING. As previously described (8, 38) , all exercise tests were performed with the participant in an upright position on an electronically braked cycle ergometer, with the pedal rate at w60 rpm.
At the initial screening visit, a maximal, graded (10-W per minute) exercise test was performed to assess peak capacity (43) . The maximal work rate was defined as the greatest work rate that could be maintained for $30 s. At all subsequent visits, a submaximal constant work rate exercise test at w75% of maximal work rate was performed. During all tests, heart rate and rhythm were monitored continuously, using an electrocardiogram, and blood pressure measurements were made at rest (following 2 min of quiet breathing) and every 2 min during the test.
Breath-by-breath gas exchange data (Medgraphics Ultima, Minneapolis, Minnesota) were measured continuously at rest and during exercise. All submaximal constant work rate tests were performed w1.5 to 2 h after the participant consumed the juice.
SUBMAXIMAL AEROBIC ENDURANCE. The submaximal constant work rate exercise test began with a 2-min period of unloaded pedaling followed by an immediate increase to the specified submaximal work rate, which was maintained until volitional exhaustion. In addition, the test was terminated if the pedal rate fell below 50 rpm for w10 s. Submaximal work rate was initially prescribed at 75% of maximal power output. At the second visit (pre-randomization), the adequacy of this work rate was confirmed. If the participant was not able to maintain the work rate for $4 min, the work rate was decreased by w10 W for subsequent tests. Likewise, if the participant was able to maintain the work rate for $10 min, the work rate was increased by w10 W for subsequent tests.
Importantly, the submaximal work rate was the same for all post-randomization efficacy visits. (Figure 2, Tables 2 and 3) .
With both the single, acute and the 1 week of daily doses, there were no differences between VO 2 in the BRJ group and that in the placebo group at rest or at any time point measured during exercise, including at volitional exhaustion ( Figure 3) . Notably, mean respiratory exchange ratio at exhaustion was >1.15 with all treatments, indicating that, although a work rate of w75% of maximal was used, a similar exhaustive, severe intensity level was reached at the end of the test. Finally, with both the single, acute and 1 week of daily doses, there were no differences in heart rate or gas exchange measurements at volitional exhaustion (Tables 2 and 3 ). Values are mean AE SD, or n (%). *BNP median (25th to 75th percentiles) was 15 (9-24).
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blocker; BMI ¼ body mass index; BNP ¼ B-type natriuretic peptide; BP ¼ blood pressure; E ¼ early mitral velocity; e 0 ¼ mitral annulus velocity; HFpEF ¼ heart failure with preserved ejection fraction; Hx ¼ history; NYHA ¼ New York Heart Association.
FI GURE 1 Plasma Nitrite and Nitrate
Mean AE SE of plasma nitrite and plasma nitrate after a single acute dose (A) and after 1 week of daily dosing (B). Open columns are placebo, and solid columns are beet root juice. *p < 0.05; **p < 0.001.
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Beetroot Juice Supplementation in HFpEF Abbreviations as in Table 2 . One week of daily doses with BRJ improved submaximal aerobic endurance; no significant effect was found for this outcome with a single, acute BRJ dose.
However, a recent study by Zamani et al. (37) observed an increase in total work performed after a single, acute dose of BRJ in HFpEF patients compared to that in placebo patients in a cross-over study (37) . These investigators also observed increased cardiac output, decreased systemic vascular resistance, and reduced aortic augmentation index due to BRJ compared to placebo, but no improvement in exercise efficiency (total work/total oxygen consumed) was observed (37), a finding confirmed in our study ( Figure 3) .
It is important to note that our study used a 6.1-mmol dose, whereas Zamani et al. (37) administered a 12.9-mmol dose of NO 3 -. A larger nitrate dose results in increased plasma nitrite (45) which is the essential factor in producing physiological changes.
The dose we administered resulted in significantly higher plasma nitrite than with placebo ( Figure 1 ), but the response was also variable. Comparison of the 2 studies suggests that a higher nitrate dose may be more effective, at least for acute, single-dose effects.
The fact that we observed positive effects at the smaller dose we used with the chronic but not with the acute dose schedule is consistent with some previous observations (29, 31 ). That we did not see an improvement in VO 2 suggests that intrinsic Eggebeen et al.
Beetroot Juice Supplementation in HFpEF Thus, a much larger study should be undertaken to examine both acute (single dose) and chronic (over several weeks) doses of BRJ at several levels of NO 3 -.
CONCLUSIONS
Our finding that submaximal aerobic endurance was increased at a lower blood pressure suggests that HFpEF patients could potentially perform submaximal exercise at a lower intensity and for longer periods which has implications for everyday activities.
Given that a hallmark feature of HFpEF is exercise intolerance even while performing submaximal exercise, our findings may have important functional and therapeutic implications. Beetroot Juice Supplementation in HFpEF J U N E 2 0 1 6 : 4 2 8 -3 7
